BOSTON SCIENTIFIC CORPORATION Increase (Decrease) in Accounts Receivable
BOSTON SCIENTIFIC CORPORATION (BSX) reported Increase (Decrease) in Accounts Receivable of $163.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-03
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $46.00M, a 43.75% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $117.00M, a 9.35% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $98.00M, a 8.89% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $32.00M, a 3.03% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in accounts receivable for fiscal 2025 was $269.00M, a 23.36% decline from fiscal 2024.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in accounts receivable for fiscal 2024 was $351.00M, a 47.48% increase from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in accounts receivable for fiscal 2023 was $238.00M, a 8.18% increase from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in accounts receivable for fiscal 2022 was $220.00M, a 21.15% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $46.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $163.00M 10-Q · filed 2026-08-03 | $261.00M derived: sum of 3 quarters · filed 2026-08-03 | $293.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $117.00M 10-Q · filed 2026-05-01 | $215.00M derived: sum of 2 quarters · filed 2026-05-01 | $247.00M derived: sum of 3 quarters · filed 2026-05-01 | $279.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $98.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $130.00M derived: sum of 2 quarters · filed 2026-02-17 | $162.00M derived: sum of 3 quarters · filed 2026-08-03 | $269.00M 10-K · filed 2026-02-17 |
| 2025-09-30 | $32.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $64.00M derived: sum of 2 quarters · filed 2026-08-03 | $171.00M 10-Q · filed 2025-11-03 | $261.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $32.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $139.00M 10-Q · filed 2026-08-03 | $229.00M derived: sum of 3 quarters · filed 2026-08-03 | $262.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $107.00M 10-Q · filed 2026-05-01 | $197.00M derived: sum of 2 quarters · filed 2026-05-01 | $230.00M derived: sum of 3 quarters · filed 2026-05-01 | $344.00M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $90.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $123.00M derived: sum of 2 quarters · filed 2026-02-17 | $237.00M derived: sum of 3 quarters · filed 2026-02-17 | $351.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $33.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $147.00M derived: sum of 2 quarters · filed 2025-11-03 | $261.00M 10-Q · filed 2025-11-03 | $335.00M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $114.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $228.00M 10-Q · filed 2025-08-01 | $302.00M derived: sum of 3 quarters · filed 2026-02-17 | $305.00M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $114.00M 10-Q · filed 2025-05-01 | $188.00M derived: sum of 2 quarters · filed 2026-02-17 | $191.00M derived: sum of 3 quarters · filed 2026-02-17 | $266.00M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $74.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $77.00M derived: sum of 2 quarters · filed 2026-02-17 | $152.00M derived: sum of 3 quarters · filed 2026-02-17 | $238.00M 10-K · filed 2026-02-17 |
| 2023-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $78.00M derived: sum of 2 quarters · filed 2024-11-01 | $164.00M 10-Q · filed 2024-11-01 | $208.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $75.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $161.00M 10-Q · filed 2024-08-01 | $205.00M derived: sum of 3 quarters · filed 2025-02-18 | $219.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $86.00M 10-Q · filed 2024-05-01 | $130.00M derived: sum of 2 quarters · filed 2025-02-18 | $144.00M derived: sum of 3 quarters · filed 2025-02-18 | $240.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $44.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $58.00M derived: sum of 2 quarters · filed 2025-02-18 | $154.00M derived: sum of 3 quarters · filed 2025-02-18 | $220.00M 10-K · filed 2025-02-18 |
| 2022-09-30 | $14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $110.00M derived: sum of 2 quarters · filed 2023-11-01 | $176.00M 10-Q · filed 2023-11-01 | $324.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $96.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $162.00M 10-Q · filed 2023-08-03 | $310.00M derived: sum of 3 quarters · filed 2024-02-20 | $296.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $66.00M 10-Q · filed 2023-05-04 | $214.00M derived: sum of 2 quarters · filed 2024-02-20 | $200.00M derived: sum of 3 quarters · filed 2024-02-20 | $228.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $148.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $134.00M derived: sum of 2 quarters · filed 2024-02-20 | $162.00M derived: sum of 3 quarters · filed 2024-02-20 | $279.00M 10-K · filed 2024-02-20 |
| 2021-09-30 | -$14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $14.00M derived: sum of 2 quarters · filed 2022-11-03 | $131.00M 10-Q · filed 2022-11-03 | $38.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $28.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $145.00M 10-Q · filed 2022-08-04 | $52.00M derived: sum of 3 quarters · filed 2023-02-23 | $175.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $117.00M 10-Q · filed 2022-05-05 | $24.00M derived: sum of 2 quarters · filed 2023-02-23 | $147.00M derived: sum of 3 quarters · filed 2023-02-23 | -$57.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$93.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $30.00M derived: sum of 2 quarters · filed 2023-02-23 | -$174.00M derived: sum of 3 quarters · filed 2023-02-23 | -$335.00M 10-K · filed 2023-02-23 |
| 2020-09-30 | $123.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$81.00M derived: sum of 2 quarters · filed 2021-11-04 | -$242.00M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$204.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$365.00M 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | -$161.00M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $130.00M 10-K · filed 2022-02-23 | |||
| 2018-12-31 | $110.00M 10-K · filed 2021-02-23 | |||
| 2017-12-31 | $30.00M 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $216.00M 10-K · filed 2019-02-19 | |||
| 2015-12-31 | $17.00M 10-K · filed 2018-02-20 | |||
| 2014-12-31 | -$53.00M 10-K · filed 2017-02-23 | |||
| 2013-12-31 | $101.00M 10-K · filed 2016-02-24 | |||
| 2012-12-31 | -$37.00M 10-K · filed 2015-02-25 | |||
| 2011-12-31 | -$42.00M 10-K · filed 2014-02-26 | |||
| 2010-12-31 | -$52.00M 8-K · filed 2013-05-29 | |||
| 2009-12-31 | -$1.00M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |